Company intelligence / Profile preview

Avantome

Menlo Park, California, United States

Ownership: Private
Development stage: Other

Overview

Avantome developed a next-generation, semiconductor-based DNA sequencing platform to dramatically reduce the cost and complexity of genomics; its core technology formed the basis for Illumina's iSEQ system. The company had no therapeutics pipeline; focus was on technology development for broad genomics applications, not clinical candidates.

Modalities: DeviceDNA sequencing platformGenomics technology
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Avantome.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avantome.

Explore the full profile